{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:00:22Z","timestamp":1788897622090,"version":"build-2803163510"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T00:00:00Z","timestamp":1639958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T00:00:00Z","timestamp":1639958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Aging"],"DOI":"10.1038\/s43587-021-00149-w","type":"journal-article","created":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T12:09:34Z","timestamp":1640002174000},"page":"60-73","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Alzheimer\u2019s disease modification mediated by bone marrow-derived macrophages via a TREM2-independent pathway in mouse model of amyloidosis"],"prefix":"10.1038","volume":"2","author":[{"given":"Raz","family":"Dvir-Szternfeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0611-5250","authenticated-orcid":false,"given":"Giulia","family":"Castellani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Arad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liora","family":"Cahalon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Phoebeluc","family":"Colaiuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadas","family":"Keren-Shaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3805-3429","authenticated-orcid":false,"given":"Tommaso","family":"Croese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5517-8223","authenticated-orcid":false,"given":"Chiara","family":"Burgaletto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuti","family":"Baruch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Ulland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5222-4987","authenticated-orcid":false,"given":"Marco","family":"Colonna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5389-9668","authenticated-orcid":false,"given":"Assaf","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2968-877X","authenticated-orcid":false,"given":"Ido","family":"Amit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4015-7507","authenticated-orcid":false,"given":"Michal","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,20]]},"reference":[{"key":"149_CR1","doi-asserted-by":"publisher","first-page":"15056","DOI":"10.1038\/nrdp.2015.56","volume":"1","author":"CL Masters","year":"2015","unstructured":"Masters, C. L. et al. Alzheimer\u2019s disease. Nat. Rev. Dis. Primers 1, 15056 (2015).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"149_CR2","doi-asserted-by":"publisher","first-page":"a006262","DOI":"10.1101\/cshperspect.a006262","volume":"2","author":"CL Masters","year":"2012","unstructured":"Masters, C. L. & Selkoe, D. J. Biochemistry of amyloid beta-protein and amyloid deposits in Alzheimer disease. Cold Spring Harb. Perspect. Med. 2, a006262 (2012).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"149_CR3","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nature04533","volume":"440","author":"S Lesne","year":"2006","unstructured":"Lesne, S. et al. A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440, 352\u2013357 (2006).","journal-title":"Nature"},{"key":"149_CR4","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/nchem.247","volume":"1","author":"SL Bernstein","year":"2009","unstructured":"Bernstein, S. L. et al. Amyloid-beta protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer\u2019s disease. Nat. Chem. 1, 326\u2013331 (2009).","journal-title":"Nat. Chem."},{"key":"149_CR5","doi-asserted-by":"publisher","first-page":"8895","DOI":"10.1073\/pnas.1820585116","volume":"116","author":"D Shea","year":"2019","unstructured":"Shea, D. et al. alpha-Sheet secondary structure in amyloid beta-peptide drives aggregation and toxicity in Alzheimer\u2019s disease. Proc. Natl Acad. Sci. USA 116, 8895\u20138900 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"149_CR6","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ebiom.2016.03.035","volume":"6","author":"U Sengupta","year":"2016","unstructured":"Sengupta, U., Nilson, A. N. & Kayed, R. The role of amyloid-beta oligomers in toxicity, propagation, and immunotherapy. EBioMed. 6, 42\u201349 (2016).","journal-title":"EBioMed."},{"key":"149_CR7","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe, D. J. & Hardy, J. The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol. Med. 8, 595\u2013608 (2016).","journal-title":"EMBO Mol. Med."},{"key":"149_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3389\/fncel.2015.00191","volume":"9","author":"ST Ferreira","year":"2015","unstructured":"Ferreira, S. T., Lourenco, M. V., Oliveira, M. M., De & Felice, F. G. Soluble amyloid-beta oligomers as synaptotoxins leading to cognitive impairment in Alzheimer\u2019s disease. Front. Cell. Neurosci. 9, 191 (2015).","journal-title":"Front. Cell. Neurosci."},{"key":"149_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41582-018-0116-6","volume":"15","author":"F Panza","year":"2019","unstructured":"Panza, F., Lozupone, M., Logroscino, G. & Imbimbo, B. P. A critical appraisal of amyloid-beta-targeting therapies for Alzheimer disease. Nat. Rev. Neurol. 15, 73\u201388 (2019).","journal-title":"Nat. Rev. Neurol."},{"key":"149_CR10","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nrneurol.2013.223","volume":"9","author":"E Giacobini","year":"2013","unstructured":"Giacobini, E. & Gold, G. Alzheimer disease therapy\u2013moving from amyloid-beta to tau. Nat. Rev. Neurol. 9, 677\u2013686 (2013).","journal-title":"Nat. Rev. Neurol."},{"key":"149_CR11","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","volume":"14","author":"EE Congdon","year":"2018","unstructured":"Congdon, E. E. & Sigurdsson, E. M. Tau-targeting therapies for Alzheimer disease. Nat. Rev. Neurol. 14, 399\u2013415 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"149_CR12","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.neuron.2006.01.022","volume":"49","author":"AR Simard","year":"2006","unstructured":"Simard, A. R., Soulet, D., Gowing, G., Julien, J. P. & Rivest, S. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer\u2019s disease. Neuron 49, 489\u2013502 (2006).","journal-title":"Neuron"},{"key":"149_CR13","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/nm1781","volume":"14","author":"T Town","year":"2008","unstructured":"Town, T. et al. Blocking TGF-beta-Smad2\/3 innate immune signaling mitigates Alzheimer-like pathology. Nat. Med. 14, 681\u2013687 (2008).","journal-title":"Nat. Med."},{"key":"149_CR14","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka, M. T. et al. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 14, 388\u2013405 (2015).","journal-title":"Lancet Neurol."},{"key":"149_CR15","doi-asserted-by":"crossref","unstructured":"Dong, Y., Li, X., Cheng, J. & Hou, L. Drug development for Alzheimer\u2019s disease: microglia induced neuroinflammation as a target? Int. J. Mol. Sci. 20, 558 (2019).","DOI":"10.3390\/ijms20030558"},{"key":"149_CR16","doi-asserted-by":"publisher","first-page":"11784","DOI":"10.1073\/pnas.0604681103","volume":"103","author":"O Butovsky","year":"2006","unstructured":"Butovsky, O. et al. Glatiramer acetate fights against Alzheimer\u2019s disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. Proc. Natl Acad. Sci. USA 103, 11784\u201311789 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"149_CR17","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","volume":"160","author":"Y Wang","year":"2015","unstructured":"Wang, Y. et al. TREM2 lipid sensing sustains the microglial response in an Alzheimer\u2019s disease model. Cell 160, 1061\u20131071 (2015).","journal-title":"Cell"},{"key":"149_CR18","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nm.4022","volume":"22","author":"K Baruch","year":"2016","unstructured":"Baruch, K. et al. PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer\u2019s disease. Nat. Med. 22, 135\u2013137 (2016).","journal-title":"Nat. Med."},{"key":"149_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08352-5","volume":"10","author":"N Rosenzweig","year":"2019","unstructured":"Rosenzweig, N. et al. PD-1\/PD-L1 checkpoint blockade harnesses monocyte-derived macrophages to combat cognitive impairment in a tauopathy mouse model. Nat. Commun. 10, 465 (2019).","journal-title":"Nat. Commun."},{"key":"149_CR20","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul, H. et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 169, 1276\u20131290 (2017).","journal-title":"Cell"},{"key":"149_CR21","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41586-018-0368-8","volume":"560","author":"S Da Mesquita","year":"2018","unstructured":"Da Mesquita, S. et al. Functional aspects of meningeal lymphatics in ageing and Alzheimer\u2019s disease. Nature 560, 185\u2013191 (2018).","journal-title":"Nature"},{"key":"149_CR22","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1093\/brain\/awv150","volume":"138","author":"Y Koronyo","year":"2015","unstructured":"Koronyo, Y. et al. Therapeutic effects of glatiramer acetate and grafted CD115+ monocytes in a mouse model of Alzheimer\u2019s disease. Brain 138, 2399\u20132422 (2015).","journal-title":"Brain"},{"key":"149_CR23","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.immuni.2016.02.015","volume":"44","author":"TA Wynn","year":"2016","unstructured":"Wynn, T. A. & Vannella, K. M. Macrophages in tissue repair, regeneration, and fibrosis. Immunity 44, 450\u2013462 (2016).","journal-title":"Immunity"},{"key":"149_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semcdb.2016.08.006","volume":"61","author":"CM Minutti","year":"2017","unstructured":"Minutti, C. M., Knipper, J. A., Allen, J. E. & Zaiss, D. M. Tissue-specific contribution of macrophages to wound healing. Semin. Cell Dev. Biol. 61, 3\u201311 (2017).","journal-title":"Semin. Cell Dev. Biol."},{"key":"149_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0952-7915(01)00307-7","volume":"14","author":"L Peiser","year":"2002","unstructured":"Peiser, L., Mukhopadhyay, S. & Gordon, S. Scavenger receptors in innate immunity. Curr. Opin. Immunol. 14, 123\u2013128 (2002).","journal-title":"Curr. Opin. Immunol."},{"key":"149_CR26","doi-asserted-by":"publisher","first-page":"a020537","DOI":"10.1101\/cshperspect.a020537","volume":"7","author":"F Ginhoux","year":"2015","unstructured":"Ginhoux, F. & Prinz, M. Origin of microglia: current concepts and past controversies. Cold Spring Harb. Perspect. Biol. 7, a020537 (2015).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"149_CR27","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/nn1997","volume":"10","author":"UK Hanisch","year":"2007","unstructured":"Hanisch, U. K. & Kettenmann, H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 10, 1387\u20131394 (2007).","journal-title":"Nat. Neurosci."},{"key":"149_CR28","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley, H. et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J. Neurosci. 26, 10129\u201310140 (2006).","journal-title":"J. Neurosci."},{"key":"149_CR29","doi-asserted-by":"crossref","unstructured":"Guerreiro, R. et al. TREM2 variants in Alzheimer\u2019s disease. N. Engl. J. Med. 368, 117\u2013127 (2013).","DOI":"10.1056\/NEJMoa1211851"},{"key":"149_CR30","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1038\/nn2014","volume":"10","author":"B Ajami","year":"2007","unstructured":"Ajami, B., Bennett, J. L., Krieger, C., Tetzlaff, W. & Rossi, F. M. Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat. Neurosci. 10, 1538\u20131543 (2007).","journal-title":"Nat. Neurosci."},{"key":"149_CR31","doi-asserted-by":"publisher","first-page":"e1000113","DOI":"10.1371\/journal.pmed.1000113","volume":"6","author":"R Shechter","year":"2009","unstructured":"Shechter, R. et al. Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med. 6, e1000113 (2009).","journal-title":"PLoS Med."},{"key":"149_CR32","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.immuni.2013.02.012","volume":"38","author":"R Shechter","year":"2013","unstructured":"Shechter, R. et al. Recruitment of beneficial M2 macrophages to injured spinal cord is orchestrated by remote brain choroid plexus. Immunity 38, 555\u2013569 (2013).","journal-title":"Immunity"},{"key":"149_CR33","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.neuron.2015.01.013","volume":"85","author":"SP Gadani","year":"2015","unstructured":"Gadani, S. P., Walsh, J. T., Smirnov, I., Zheng, J. & Kipnis, J. The glia-derived alarmin IL-33 orchestrates the immune response and promotes recovery following CNS injury. Neuron 85, 703\u2013709 (2015).","journal-title":"Neuron"},{"key":"149_CR34","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1111\/j.1471-4159.2009.06402.x","volume":"111","author":"M Koronyo-Hamaoui","year":"2009","unstructured":"Koronyo-Hamaoui, M. et al. Attenuation of AD-like neuropathology by harnessing peripheral immune cells: local elevation of IL-10 and MMP-9. J. Neurochem. 111, 1409\u20131424 (2009).","journal-title":"J. Neurochem."},{"key":"149_CR35","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2119\/molmed.2011.00306","volume":"18","author":"G Naert","year":"2012","unstructured":"Naert, G. & Rivest, S. Hematopoietic CC-chemokine receptor 2 (CCR2) competent cells are protective for the cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer\u2019s disease. Mol. Med. 18, 297\u2013313 (2012).","journal-title":"Mol. Med."},{"key":"149_CR36","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13024-021-00458-z","volume":"16","author":"H Ben-Yehuda","year":"2021","unstructured":"Ben-Yehuda, H. et al. Key role of the CCR2-CCL2 axis in disease modification in a mouse model of tauopathy. Mol. Neurodegener. 16, 39 (2021).","journal-title":"Mol. Neurodegener."},{"key":"149_CR37","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.bbi.2020.09.015","volume":"91","author":"Z Xing","year":"2021","unstructured":"Xing, Z. et al. Influenza vaccine combined with moderate-dose PD1 blockade reduces amyloid-beta accumulation and improves cognition in APP\/PS1 mice. Brain Behav. Immun. 91, 128\u2013141 (2021).","journal-title":"Brain Behav. Immun."},{"key":"149_CR38","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1007\/s00018-017-2463-7","volume":"74","author":"L Zuroff","year":"2017","unstructured":"Zuroff, L., Daley, D., Black, K. L. & Koronyo-Hamaoui, M. Clearance of cerebral Abeta in Alzheimer\u2019s disease: reassessing the role of microglia and monocytes. Cell. Mol. Life Sci. 74, 2167\u20132201 (2017).","journal-title":"Cell. Mol. Life Sci."},{"key":"149_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1453-0","volume":"16","author":"DA Dionisio-Santos","year":"2019","unstructured":"Dionisio-Santos, D. A., Olschowka, J. A. & O\u2019Banion, M. K. Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer\u2019s disease. J. Neuroinflammation 16, 74 (2019).","journal-title":"J. Neuroinflammation"},{"key":"149_CR40","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nri.2017.125","volume":"18","author":"Q Li","year":"2018","unstructured":"Li, Q. & Barres, B. A. Microglia and macrophages in brain homeostasis and disease. Nat. Rev. Immunol. 18, 225\u2013242 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"149_CR41","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.tins.2020.03.012","volume":"43","author":"C Yu","year":"2020","unstructured":"Yu, C., Roubeix, C., Sennlaub, F. & Saban, D. R. Microglia versus monocytes: distinct roles in degenerative diseases of the retina. Trends Neurosci. 43, 433\u2013449 (2020).","journal-title":"Trends Neurosci."},{"key":"149_CR42","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1093\/brain\/awz364","volume":"143","author":"M Koronyo-Hamaoui","year":"2020","unstructured":"Koronyo-Hamaoui, M. et al. Peripherally derived angiotensin converting enzyme-enhanced macrophages alleviate Alzheimer-related disease. Brain 143, 336\u2013358 (2020).","journal-title":"Brain"},{"key":"149_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3030","volume":"4","author":"D Frenkel","year":"2013","unstructured":"Frenkel, D. et al. Scara1 deficiency impairs clearance of soluble amyloid-beta by mononuclear phagocytes and accelerates Alzheimer\u2019s-like disease progression. Nat. Commun. 4, 2030 (2013).","journal-title":"Nat. Commun."},{"key":"149_CR44","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1126\/science.1247651","volume":"343","author":"DA Jaitin","year":"2014","unstructured":"Jaitin, D. A. et al. Massively parallel single-cell RNA-seq for marker-free decomposition of tissues into cell types. Science 343, 776\u2013779 (2014).","journal-title":"Science"},{"key":"149_CR45","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1038\/s41596-019-0164-4","volume":"14","author":"H Keren-Shaul","year":"2019","unstructured":"Keren-Shaul, H. et al. MARS-seq2.0: an experimental and analytical pipeline for indexed sorting combined with single-cell RNA sequencing. Nat. Protoc. 14, 1841\u20131862 (2019).","journal-title":"Nat. Protoc."},{"key":"149_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1812-2","volume":"20","author":"Y Baran","year":"2019","unstructured":"Baran, Y. et al. MetaCell: analysis of single-cell RNA-seq data using K-nn graph partitions. Genome Biol. 20, 206 (2019).","journal-title":"Genome Biol."},{"key":"149_CR47","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/j.cell.2015.11.013","volume":"163","author":"F Paul","year":"2015","unstructured":"Paul, F. et al. Transcriptional heterogeneity and lineage commitment in myeloid progenitors. Cell 163, 1663\u20131677 (2015).","journal-title":"Cell"},{"key":"149_CR48","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.neuron.2019.06.010","volume":"103","author":"A Griciuc","year":"2019","unstructured":"Griciuc, A. et al. TREM2 acts downstream of CD33 in modulating microglial pathology in Alzheimer\u2019s disease. Neuron 103, 820\u2013835 (2019).","journal-title":"Neuron"},{"key":"149_CR49","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1523\/JNEUROSCI.1871-19.2019","volume":"40","author":"WJ Meilandt","year":"2020","unstructured":"Meilandt, W. J. et al. Trem2 deletion reduces late-stage amyloid plaque accumulation, elevates the Abeta42:Abeta40 ratio, and exacerbates axonal dystrophy and dendritic spine loss in the PS2APP Alzheimer\u2019s mouse model. J. Neurosci. 40, 1956\u20131974 (2020).","journal-title":"J. Neurosci."},{"key":"149_CR50","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.nbd.2003.08.009","volume":"14","author":"J Wang","year":"2003","unstructured":"Wang, J., Tanila, H., Puolivali, J., Kadish, I. & van Groen, T. Gender differences in the amount and deposition of amyloidbeta in APPswe and PS1 double transgenic mice. Neurobiol. Dis. 14, 318\u2013327 (2003).","journal-title":"Neurobiol. Dis."},{"key":"149_CR51","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/cne.24551","volume":"527","author":"JL Bundy","year":"2019","unstructured":"Bundy, J. L., Vied, C., Badger, C. & Nowakowski, R. S. Sex-biased hippocampal pathology in the 5XFAD mouse model of Alzheimer\u2019s disease: a multi-omic analysis. J. Comp. Neurol. 527, 462\u2013475 (2019).","journal-title":"J. Comp. Neurol."},{"key":"149_CR52","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.brainres.2010.10.009","volume":"1366","author":"JC Carroll","year":"2010","unstructured":"Carroll, J. C. et al. Sex differences in beta-amyloid accumulation in 3xTg-AD mice: role of neonatal sex steroid hormone exposure. Brain Res. 1366, 233\u2013245 (2010).","journal-title":"Brain Res."},{"key":"149_CR53","doi-asserted-by":"publisher","first-page":"713726","DOI":"10.3389\/fnagi.2021.713726","volume":"13","author":"AL Oblak","year":"2021","unstructured":"Oblak, A. L. et al. Comprehensive evaluation of the 5XFAD mouse model for preclinical testing applications: a MODEL-AD study. Front. Aging Neurosci. 13, 713726 (2021).","journal-title":"Front. Aging Neurosci."},{"key":"149_CR54","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nn.3028","volume":"15","author":"I Benilova","year":"2012","unstructured":"Benilova, I., Karran, E., De & Strooper, B. The toxic Abeta oligomer and Alzheimer\u2019s disease: an emperor in need of clothes. Nat. Neurosci. 15, 349\u2013357 (2012).","journal-title":"Nat. Neurosci."},{"key":"149_CR55","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nm.4312","volume":"23","author":"T Shichita","year":"2017","unstructured":"Shichita, T. et al. MAFB prevents excess inflammation after ischemic stroke by accelerating clearance of damage signals through MSR1. Nat. Med. 23, 723\u2013732 (2017).","journal-title":"Nat. Med."},{"key":"149_CR56","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.neuron.2016.06.015","volume":"91","author":"FL Yeh","year":"2016","unstructured":"Yeh, F. L., Wang, Y., Tom, I., Gonzalez, L. C. & Sheng, M. TREM2 binds to apolipoproteins, including APOE and CLU\/APOJ, and thereby facilitates uptake of amyloid-beta by microglia. Neuron 91, 328\u2013340 (2016).","journal-title":"Neuron"},{"key":"149_CR57","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1084\/jem.20101202","volume":"208","author":"A London","year":"2011","unstructured":"London, A. et al. Neuroprotection and progenitor cell renewal in the injured adult murine retina requires healing monocyte-derived macrophages. J. Exp. Med. 208, 23\u201339 (2011).","journal-title":"J. Exp. Med."},{"key":"149_CR58","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.immuni.2018.01.011","volume":"48","author":"D Mrdjen","year":"2018","unstructured":"Mrdjen, D. et al. High-dimensional single-cell mapping of central nervous system immune cells reveals distinct myeloid subsets in health, aging, and disease. Immunity 48, 380\u2013395 (2018).","journal-title":"Immunity"},{"key":"149_CR59","doi-asserted-by":"publisher","first-page":"eaat7554","DOI":"10.1126\/science.aat7554","volume":"363","author":"MJC Jordao","year":"2019","unstructured":"Jordao, M. J. C. et al. Single-cell profiling identifies myeloid cell subsets with distinct fates during neuroinflammation. Science 363, eaat7554 (2019).","journal-title":"Science"},{"key":"149_CR60","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jaci.2017.04.049","volume":"141","author":"Y Zhou","year":"2018","unstructured":"Zhou, Y. et al. Mannose receptor modulates macrophage polarization and allergic inflammation through miR-511-3p. J. Allergy Clin. Immunol. 141, 350\u2013364 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"149_CR61","doi-asserted-by":"publisher","first-page":"1683347","DOI":"10.1080\/2162402X.2019.1683347","volume":"9","author":"ZJ Xu","year":"2020","unstructured":"Xu, Z. J. et al. The M2 macrophage marker CD206: a novel prognostic indicator for acute myeloid leukemia. Oncoimmunology 9, 1683347 (2020).","journal-title":"Oncoimmunology"},{"key":"149_CR62","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41564-018-0280-x","volume":"4","author":"K Subramanian","year":"2019","unstructured":"Subramanian, K. et al. Pneumolysin binds to the mannose receptor C type 1 (MRC-1) leading to anti-inflammatory responses and enhanced pneumococcal survival. Nat. Microbiol. 4, 62\u201370 (2019).","journal-title":"Nat. Microbiol."},{"key":"149_CR63","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1016\/j.cell.2021.04.003","volume":"184","author":"N Dani","year":"2021","unstructured":"Dani, N. et al. A cellular and spatial map of the choroid plexus across brain ventricles and ages. Cell 184, 3056\u20133074 (2021).","journal-title":"Cell"},{"key":"149_CR64","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1084\/jem.20151948","volume":"213","author":"Y Wang","year":"2016","unstructured":"Wang, Y. et al. TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques. J. Exp. Med. 213, 667\u2013675 (2016).","journal-title":"J. Exp. Med."},{"key":"149_CR65","doi-asserted-by":"crossref","unstructured":"Reed-Geaghan, E. G., Croxford, A. L., Becher, B. & Landreth, G. E. Plaque-associated myeloid cells derive from resident microglia in an Alzheimer\u2019s disease model. J. Exp. Med. 217, e20191374 (2020).","DOI":"10.1084\/jem.20191374"},{"key":"149_CR66","doi-asserted-by":"crossref","unstructured":"Schoch, K. M. et al. Acute Trem2 reduction triggers increased microglial phagocytosis, slowing amyloid deposition in mice. Proc. Natl Acad. Sci. USA 118, e2100356118 (2021).","DOI":"10.1073\/pnas.2100356118"},{"key":"149_CR67","doi-asserted-by":"publisher","first-page":"109228","DOI":"10.1016\/j.celrep.2021.109228","volume":"35","author":"Y Hu","year":"2021","unstructured":"Hu, Y. et al. Replicative senescence dictates the emergence of disease-associated microglia and contributes to Abeta pathology. Cell Rep. 35, 109228 (2021).","journal-title":"Cell Rep."},{"key":"149_CR68","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.brainres.2012.02.041","volume":"1450","author":"JM McDonald","year":"2012","unstructured":"McDonald, J. M., Cairns, N. J., Taylor-Reinwald, L., Holtzman, D. & Walsh, D. M. The levels of water-soluble and triton-soluble Abeta are increased in Alzheimer\u2019s disease brain. Brain Res. 1450, 138\u2013147 (2012).","journal-title":"Brain Res."},{"key":"149_CR69","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/glia.23260","volume":"66","author":"M Latta-Mahieu","year":"2018","unstructured":"Latta-Mahieu, M. et al. Systemic immune-checkpoint blockade with anti-PD1 antibodies does not alter cerebral amyloid-beta burden in several amyloid transgenic mouse models. Glia 66, 492\u2013504 (2018).","journal-title":"Glia"},{"key":"149_CR70","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","volume":"71","author":"PT Nelson","year":"2012","unstructured":"Nelson, P. T. et al. Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J. Neuropathol. Exp. Neurol. 71, 362\u2013381 (2012).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"149_CR71","doi-asserted-by":"publisher","first-page":"e183597","DOI":"10.1001\/jamanetworkopen.2018.3597","volume":"1","author":"Q Tao","year":"2018","unstructured":"Tao, Q. et al. Association of chronic low-grade inflammation with risk of Alzheimer disease in ApoE4 carriers. JAMA Netw. Open 1, e183597 (2018).","journal-title":"JAMA Netw. Open"},{"key":"149_CR72","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.brainresbull.2012.08.003","volume":"89","author":"B Misiak","year":"2012","unstructured":"Misiak, B., Leszek, J. & Kiejna, A. Metabolic syndrome, mild cognitive impairment and Alzheimer\u2019s disease\u2013the emerging role of systemic low-grade inflammation and adiposity. Brain Res. Bull. 89, 144\u2013149 (2012).","journal-title":"Brain Res. Bull."},{"key":"149_CR73","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cell.2017.07.023","volume":"170","author":"TK Ulland","year":"2017","unstructured":"Ulland, T. K. et al. TREM2 maintains microglial metabolic fitness in Alzheimer\u2019s disease. Cell 170, 649\u2013663 (2017).","journal-title":"Cell"},{"key":"149_CR74","doi-asserted-by":"publisher","first-page":"e1075114","DOI":"10.1080\/2162402X.2015.1075114","volume":"5","author":"C Mall","year":"2016","unstructured":"Mall, C. et al. Repeated PD-1\/PD-L1 monoclonal antibody administration induces fatal xenogeneic hypersensitivity reactions in a murine model of breast cancer. Oncoimmunology 5, e1075114 (2016).","journal-title":"Oncoimmunology"},{"key":"149_CR75","doi-asserted-by":"publisher","first-page":"4697","DOI":"10.4049\/jimmunol.166.7.4697","volume":"166","author":"M Mack","year":"2001","unstructured":"Mack, M. et al. Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice. J. Immunol. 166, 4697\u20134704 (2001).","journal-title":"J. Immunol."},{"key":"149_CR76","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1002\/art.22854","volume":"56","author":"H Bruhl","year":"2007","unstructured":"Bruhl, H. et al. Targeting of Gr-1+,CCR2+ monocytes in collagen-induced arthritis. Arthritis Rheum. 56, 2975\u20132985 (2007).","journal-title":"Arthritis Rheum."},{"key":"149_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8967","volume":"6","author":"K Baruch","year":"2015","unstructured":"Baruch, K. et al. Breaking immune tolerance by targeting Foxp3(+) regulatory T cells mitigates Alzheimer\u2019s disease pathology. Nat. Commun. 6, 7967 (2015).","journal-title":"Nat. Commun."},{"key":"149_CR78","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676\u2013682 (2012).","journal-title":"Nat. Methods"},{"key":"149_CR79","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1038\/nprot.2006.275","volume":"1","author":"J Alamed","year":"2006","unstructured":"Alamed, J., Wilcock, D. M., Diamond, D. M., Gordon, M. N. & Morgan, D. Two-day radial-arm water maze learning and memory task; robust resolution of amyloid-related memory deficits in transgenic mice. Nat. Protoc. 1, 1671\u20131679 (2006).","journal-title":"Nat. Protoc."},{"key":"149_CR80","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1038\/nprot.2006.205","volume":"1","author":"RA Bevins","year":"2006","unstructured":"Bevins, R. A. & Besheer, J. Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study \u2018recognition memory\u2019. Nat. Protoc. 1, 1306\u20131311 (2006).","journal-title":"Nat. Protoc."}],"container-title":["Nature Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43587-021-00149-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43587-021-00149-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43587-021-00149-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T04:05:23Z","timestamp":1722917123000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43587-021-00149-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,20]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["149"],"URL":"https:\/\/doi.org\/10.1038\/s43587-021-00149-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-113877\/v1","asserted-by":"object"}]},"ISSN":["2662-8465"],"issn-type":[{"value":"2662-8465","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,20]]},"assertion":[{"value":"22 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.S. is an inventor of the intellectual property that forms the basis for development of PD-L1 immunotherapy for AD. K.B. is coinventor of the intellectual property that forms the basis for development of PD-L1 immunotherapy for AD. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}